S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis

Xiaolin Liu(The Fifth People’s Hospital of Suzhou), Yimin Mao(Shaoguan University), Xiaoyu Chen(Shanghai Jiao Tong University), Jingyi Zhang(Chengdu University of Traditional Chinese Medicine), Yongfeng Wang(Shanxi Medical University), Minde Zeng(Renji Hospital), Yanyan Song(Shanghai Jiao Tong University), Yanan Ming(Shanghai Jiao Tong University)
PLoS ONE
May 19, 2015
10.1371/journal.pone.0127352
Cited by 31

Related Papers

Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
|Experimental & Molecular Medicine|2018|212
Catalytic degradation of micropollutant by peroxymonosulfate activation through Fe(III)/Fe(II) cycle confined in the nanoscale interlayer of Fe(III)-saturated montmorillonite
|Water Research|2020|116